CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 43 enrolled
Drug / intervention
Saline +1 moredrug
Likely dose
Saline 40 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03856788
NCT03856788Phase 4Completed
CompareCT.gov

Effect of Unilateral Ultrasound-Guided Subcostal Transversus Abdominis Plane Block in Patients Undergoing Laparoscopic Sleeve Gastrectomy

Icahn School of Medicine at Mount Sinai·interventional·Posted Feb 27, 2019·Updated Oct 17, 2022

In Brief

A Phase 4 clinical trial evaluating Saline and Bupivacaine for Laparoscopic Sleeve Gastrectomy and Subcostal Transversus Abdominis Plane Block. Completed, enrolled 43 participants across 1 site.

Detailed Summary

The study team will be assessing if the unilateral subcostal transversus abdominis plane (TAP) block can decrease pain and improve outcomes following laparoscopic sleeve gastrectomy surgeries.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaparoscopic Sleeve Gastrectomy, Subcostal Transversus Abdominis Plane Block
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedFeb 27, 2019
Enrollment StartDec 10, 2018
Primary CompletionMar 25, 2021
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 7.3 years ago

Interventions

Salinedrug

40 mL sterile normal saline

Bupivacainedrug

40 mL 0.25% bupivacaine